Portugal

 

Healthcare Activos raises new fund worth €650m

Pan-European Spanish healthcare real estate investor Healthcare Activos has launched a new investment fund worth €650 million. This is the REIT’s second fund, and will, in contrast to the first fund, be primarily focused on making investments outside of Spain and Portugal. Jorge Guarner, Activos’ President and Founder, tells us more.

Fidelidade targets €500m RT1 green capital raise

Fidelidade, Portugal’s largest health insurer, is preparing a green bond sale that could raise up to €500 million, in what would be a first issuance of sustainable capital instruments by a European insurer.

Fidelidade announces 2025 IPO, cancels IPO of subsidiary Luz Saúde

Portuguese insurance company Fidelidade has outlined its plans for a 2025 initial public offering (IPO), following a strategic reassessment that includes the cancellation of the planned listing of its hospital subsidiary, Luz Saúde. The move signals a shift in strategy for Fidelidade, which is majority-owned by China’s Fosun International.

Luz Saude IPO to finally go ahead

Luz Saude, Portugal’s second largest private hospital group by revenue, will become a listed company once again, six years after it was taken private by its insurer-owner, Fidelidade. The company has confirmed an IPO on Portugal’s Euronext Lisbon exchange will go ahead, almost a year after reports of plans to relist initially began circulating.

Orpea raids ramp up

While inspections at facilities belonging to French multinational elderly care operator Orpea have been commonplace within France, news of Europe-wide police raids sweeping Belgium, Luxembourg, Italy, Portugal and Switzerland is now making headlines.

HR Round Up

January comes to an end, rounding off what has been a busy period in personnel changes. We review some of the senior appointments that kicked off the new year including at UK care home operator Cornerstone, property advisor Christie & Co, and healthcare conglomerate Fresenius.

New AI act could stifle EU innovation – but benefit the UK

After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.

Eugin sells for €500m

Healthcare conglomerate Fresenius has sold Eugin, its Spain-based fertility business, to KKR-owned fertility group IVI RMA and Spain-based asset management firm GED for €500m including earn-outs.

Why it pays to do the basics when building a patient pathway

A German outpatient operator tells HBI how providers are attracting and keeping patients within their businesses throughout the patient pathway, with as many as 50% of complex ophthalmology referrals coming from internal sources. HBI hears it pays to do basic (less profitable) work and even consider retail early in the patient journey so when they really do need help, they already have a provider of choice.

Find Us